All-biologic Regimen Efficacious And Well-tolerated In Elderly Lung Cancer Patients, Study Suggests
Saturday, August 1, 2009 - 17:28
in Health & Medicine
Previously untreated non-small cell lung cancer patients over the age of 70 respond well to a combination of bevacizumab and erlotinib, researchers report.